Hadian Mehrnaz, Pinsky Michael R
Department of Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Crit Care. 2006;10 Suppl 3(Suppl 3):S8. doi: 10.1186/cc4834.
The pulmonary artery catheter (PAC) was introduced in 1971 for the assessment of heart function at the bedside. Since then it has generated much enthusiasm and controversy regarding the benefits and potential harms caused by this invasive form of hemodynamic monitoring. This review discusses all clinical studies conducted during the past 30 years, in intensive care unit settings or post mortem, on the impact of the PAC on outcomes and complications resulting from the procedure. Although most of the historical observational studies and randomized clinical trials also looked at PAC-related complications among their end-points, we opted to review the data under two main topics: the impact of PAC on clinical outcomes and cost-effectiveness, and the major complications related to the use of the PAC.
肺动脉导管(PAC)于1971年被引入用于床边心脏功能评估。从那时起,它就引发了关于这种有创血流动力学监测形式所带来的益处和潜在危害的诸多热情与争议。本综述讨论了过去30年在重症监护病房环境或尸检中进行的所有临床研究,这些研究涉及PAC对该操作所导致的结局和并发症的影响。尽管大多数历史观察性研究和随机临床试验在其终点中也关注了与PAC相关的并发症,但我们选择在两个主要主题下回顾数据:PAC对临床结局和成本效益的影响,以及与PAC使用相关的主要并发症。